In a new job - June 3, 2026
Vitrolife Group CEO Bronwyn Brophy O’Connor steps down
Vitrolife Group has announced that CEO Bronwyn Brophy O’Connor has decided to leave the company to take up a CEO role in another area of the medtech industry.
Financing - June 3, 2026
Stayble Therapeutics files for bankruptcy
Stayble Therapeutics has announced that its Board of Directors has resolved to file for bankruptcy, with the application to be submitted to the Gothenburg District Court.
Agreement - June 2, 2026
Camurus and Lilly sign deal on long-acting incretin therapies
Camurus has entered a global collaboration and license agreement with Eli Lilly and Company to develop long-acting incretin-based therapies for cardiometabolic diseases using its FluidCrystal technology platform.
Collaboration - June 2, 2026
AAX Biotech in collaboration with Karolinska Institutet
The company has announced a new collaboration with the research group of Dr. Thuy Tran at the Department of Oncology-Pathology, Karolinska Institutet.
Intellectual Property - May 29, 2026
Getinge’s subsidiary Maquet Cardiovascular receives adverse jury trial verdict in patent infringement dispute
A jury in the United States District Court for the District of Massachusetts has delivered a verdict in favor of Abiomed in a patent dispute between Maquet Cardiovascular and Abiomed.
Agreement - May 26, 2026
Oncopeptides signs agreement with Salus
The agreement for distribution and commercialization of Pepaxti in Central and Eastern Europe addresses a market potential of approximately SEK 150 million and enables potential sales uptake in this region earlier than previously planned, the company states.
